Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma (Q47661011)

4 February 2018

http://europepmc.org/abstract/MED/29025272

title

Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29025272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Parvin Zamani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Maryam Matbou Riahi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Khadijeh Jamialahmadi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

12 October 2017

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29025272

published in

Artificial cells, nanomedicine, and biotechnology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

1301-1313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Epidemiology of hepatocellular carcinoma: consider the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Molecular targeted therapy for hepatocellular carcinoma: current and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Hepatocellular carcinoma and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Purification, crystallization, and preliminary X-ray diffraction analysis of an M.HhaI-AdoMet complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The ankyrin repeat as molecular architecture for protein recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Ankyrin repeat: a unique motif mediating protein-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin promotes the proliferation of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

YAP is a critical oncogene in human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Correlation of Gankyrin oncoprotein overexpression with histopathological grade in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin regulates cell signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

HIF-1 and tumor progression: pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Targeting retinoblastoma protein for degradation by proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin: an intriguing name for a novel regulator of p53 and RB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Intercellular adhesion, signalling and the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The Hedgehog and Wnt signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Activate NF-kappa B or die?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Nuclear factor (NF)-kappaB proteins: therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Primer: inflammasomes and interleukin 1beta in inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Mechanisms and consequences of activation of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Regulation of PTEN by Rho small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Rac1 mediates intestinal epithelial cell apoptosis via JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

siRNA Versus miRNA as Therapeutics for Gene Silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Current prospects for RNA interference-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Strategies for silencing human disease using RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

RNA interference: biology, mechanism, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Developing therapeutic microRNAs for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Curcumin as a MicroRNA Regulator in Cancer: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Progress towards in vivo use of siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Repression of protein synthesis by miRNAs: how many mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Developing microRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

The Promise of MicroRNA Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Small molecules, big targets: drug discovery faces the protein-protein interaction challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1388250

10.1080/21691401.2017.1388250

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29025272%20AND%20SRC:MED&resulttype=core&format=json